This paper considers how the pandemic-related concert-free time affected musicians' practice, specifically in relation to technique. A semi-structured interview was carried out on 22 musicians based in Switzerland (11 males, 11 females; 7 students, 15 non-students; 11 with school-aged children, 11 without school-aged children; 16 with teaching duties and 6 non-teachers). The amount of practice during the pandemic-related concert-free time was reported as different to usual by 91% and usual for only 9% of participants ( = 0.002). Forty-one percent of participants reported reduced, and 41% "fluctuating" amounts of practice. The proportion of practice time spent on technique was reported by 55% of participants to have increased and by only 9% to have decreased ( = 0.019). Of those who reported an increase in technique practice, 75% agreed this had a positive impact on technique, and only 8% disagreed ( = 0.037). Moreover, 58% considered this work to have changed their current and future practice. Participants were statistically more likely to report "never" watching online tutorials than "often" ( = 0.014), but, of those that did watch such material, 75% agreed that it had a positive impact upon their practice. Most participants created digital content during this period; only 5% produced no such material. An increased use of digital tools was reported by 55% of participants, 92% of whom described this as having a positive effect upon practice and only 8% were unsure ( = 0.022). However, in the unstructured discussion, the use of digital tools appears to be associated with mixed outcomes. Men reported significantly more frequent use of digital tools (91% vs. 45% describing this use as often, = 0.038) and spent a larger proportion of time on technique relative to their pre-pandemic habits than women ( = 0.065); moreover, a trend indicated that more women than men created digital content in the form of tutorials ( = 0.095). The exceptional situation musicians experienced during the pandemic, which introduced new aspects to musical instrument practice, and accelerated changes already underway, could lead to future work that improves practice under "normal" conditions, and exposes discrepancies between certain demographic groups.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810800 | PMC |
http://dx.doi.org/10.3389/fpsyg.2022.846953 | DOI Listing |
Background: Availability of amyloid modifying therapies will dramatically increase the need for disclosure of Alzheimer's disease (AD) related genetic and/or biomarker test results. The 21st Century Cares Act requires the immediate return of most medical test results, including AD biomarkers. A shortage of genetic counselors and dementia specialists already exists, thus driving the need for scalable methods to responsibly communicate test results.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Karolinska Institute, Stockholm, Södermanland and Uppland, Sweden.
Background: Novel anti-amyloid therapies (AAT) for Alzheimer's Disease (AD) have recently been approved in the United States, Japan and China, and are under regulatory review in Europe. Questions remain regarding the long-term effectiveness and value of these drugs when used in routine clinical practice. Data from follow-up studies will be important to inform their optimal use, including criteria for treatment initiation, monitoring strategies, stopping rules, pricing and reimbursement considerations.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Department of Neurology and Neurological Sciences Stanford University School of Medicine, Stanford, CA, USA.
Dementia patients often received one clinical diagnosis, yet most of these cases present multiple underlying pathologies. Bringing the transition from clinical-based to biological-based diagnosis holds promise with the diagnostic criteria proposed by the Alzheimer's Association (AA) Revised Criteria for Diagnosis and Staging of Alzheimer's Disease and the Neuronal Synuclein Disease Integrated Staging System (NSD-ISS). This session aims to explore the practical implications of the AA revised criteria for diagnosing and designing clinical trials in Lewy body disease (LBD).
View Article and Find Full Text PDFIt is well recognised that Alzheimer's disease and related dementia disorders (ADRD) are associated with very high societal costs. The total global costs of dementia have been estimated to over 1.3 trillion US$ annually (Wimo, Seeher et al.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Dementia Research Centre, UCL Queen Square Institute of Neurology, London, United Kingdom.
The recent positive phase 3 clinical trials of new treatments and their licensing and roll-out in the US and other countries represents a major turning point in Alzheimer's disease research. As has been the case with many other diseases, e.g.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!